| Identification | |
| Name: | (2S)-2-Ethyl-8-methyl-1-thia-4,8-diazaspiro[4,5]decan-3-one |
| Synonyms: | (2S)-2-Ethyl-8-methyl-1-thia-4,8-diazaspiro[4,5]decan-3-one;AF 267B;1-Thia-4,8-diazaspiro[4.5]decan-3-one,2-ethyl-8-methyl-,(2S)-(9CI);1-Thia-4,8-diazaspiro(4.5)decan-3-one, 2-ethyl-8-methyl-, (2S)-;Ngx 267 |
| CAS: | 503431-81-0 |
| Molecular Formula: | C10H18N2OS |
| Molecular Weight: | 0 |
| InChI: | InChI=1/C10H18N2OS/c1-3-8-9(13)11-10(14-8)4-6-12(2)7-5-10/h8H,3-7H2,1-2H3,(H,11,13)/t8-/m0/s1 |
| Molecular Structure: | ![(C10H18N2OS) (2S)-2-Ethyl-8-methyl-1-thia-4,8-diazaspiro[4,5]decan-3-one;AF 267B;1-Thia-4,8-diazaspiro[4.5]decan-...](https://img.guidechem.com/structure/503431-81-0.gif) |
| Properties | |
| Flash Point: | 195.21°C |
| Boiling Point: | 399.167°C at 760 mmHg |
| Density: | 1.171g/cm3 |
| Refractive index: | 1.569 |
| Specification: | Pale Yellow Solid usageEng:A M1 muscarinic agonist designed as an innovative therapy for Alzheimer disease |
| Flash Point: | 195.21°C |
| Storage Temperature: | Refrigerator |
| Usage: | A M1 muscarinic agonist designed as an innovative therapy for Alzheimer disease |
| Safety Data | |
 |
|
